| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.085 | 0.09 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.049 | 0.3 |